Envoy Medical Inc

CUSIP 29415V109CL ACOCHQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

84.8%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Feb 17, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 17, 2026	Glen A. Taylor	13D/A	84.8%	—	SEC
2	Feb 11, 2026	Ayrton Capital LLC	13G	7.9%	2.46M	SEC
3	Dec 8, 2025	Glen A. Taylor	13D	44.2%	—	SEC
4	Dec 26, 2024	Anzu Spac Gp I LLC	13D	11.3%	—	SEC
5	Feb 12, 2024	Aristeia Capital, L.L.C.	13G/A	—	—	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Nantahala Capital Management, LLC	7.65M	$5.09M
2	Bleichroeder LP	6.25M	$4.16M
3	Dsg Capital Advisors, LLC	625.0K	$415.7K
4	Geode Capital Management, LLC	521.8K	$347.1K
5	Focus Partners Wealth	212.7K	$141.4K
6	Arcus Capital Partners, LLC	187.6K	$124.8K
7	Northern Trust Corp	111.0K	$73.9K
8	Cibc Bancorp USA Inc.	77.9K	$51.8K
9	Morgan Stanley	73.9K	$49.2K
10	Ubs Group AG	70.5K	$46.9K